$HCA SEC Filings

Filed On	Filing
27 Oct 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
11 Sep 2026	Form 3: Schlosser Michael J, EVP and Chief Clinical Officer Holds 170.1027 shares of Common Stock
28 Aug 2026	Form 4: McAlevey Michael R, EVP & Chief Legal & Admin Off. Disposed of 7,769 shares (Other Transaction) ($3.33M)
29 Jul 2026	8-K: Creation of a Direct Financial Obligation; Other Events
28 Jul 2026	10-Q
24 Jul 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
14 Jul 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
18 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
11 May 2026	Form 4: Marks Mike A, EVP and CFO Gave 3,336 shares as a gift · Acquired 3,336 shares (Gift)
30 Apr 2026	Form 4: Frist William R, Director Received 809 shares as a grant or award
30 Apr 2026	Form 4: Frist Thomas F Iii, Director Received 1,041 shares as a grant or award
30 Apr 2026	Form 4: Smith Andrea B, Director Received 509 shares as a grant or award
30 Apr 2026	Form 4: Riley Wayne Joseph, Director Received 509 shares as a grant or award
30 Apr 2026	Form 4: Michelson Michael W, Director Received 925 shares as a grant or award
30 Apr 2026	Form 4: Johnston Hugh F, Director Received 809 shares as a grant or award
30 Apr 2026	Form 4: Deparle Nancy Ann, Director Received 509 shares as a grant or award
30 Apr 2026	Form 4: Chidsey John, Director Received 809 shares as a grant or award
30 Apr 2026	SCHEDULE 13G
30 Apr 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
29 Apr 2026	424B5

Comments